- Home
- CURI vs SIGA Comparison
CURI vs SIGA Comparison
Compare CURI & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURI
- SIGA
- Stock Information
- Founded
- CURI N/A
- SIGA 1995
- Country
- CURI United States
- SIGA United States
- Employees
- CURI N/A
- SIGA N/A
- Industry
- CURI Movies/Entertainment
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- CURI Consumer Discretionary
- SIGA Health Care
- Exchange
- CURI Nasdaq
- SIGA Nasdaq
- Market Cap
- CURI 394.5M
- SIGA 422.9M
- IPO Year
- CURI N/A
- SIGA 1997
- Fundamental
- Price
- CURI $4.82
- SIGA $6.69
- Analyst Decision
- CURI Strong Buy
- SIGA
- Analyst Count
- CURI 2
- SIGA 0
- Target Price
- CURI $5.40
- SIGA N/A
- AVG Volume (30 Days)
- CURI 952.4K
- SIGA 405.0K
- Earning Date
- CURI 08-12-2025
- SIGA 07-31-2025
- Dividend Yield
- CURI 6.64%
- SIGA 8.97%
- EPS Growth
- CURI N/A
- SIGA N/A
- EPS
- CURI N/A
- SIGA 0.67
- Revenue
- CURI $54,223,000.00
- SIGA $120,330,310.00
- Revenue This Year
- CURI $24.74
- SIGA N/A
- Revenue Next Year
- CURI $13.30
- SIGA $95.31
- P/E Ratio
- CURI N/A
- SIGA $9.97
- Revenue Growth
- CURI N/A
- SIGA N/A
- 52 Week Low
- CURI $0.99
- SIGA $4.95
- 52 Week High
- CURI $7.15
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- CURI 42.70
- SIGA 61.77
- Support Level
- CURI $5.20
- SIGA $6.34
- Resistance Level
- CURI $5.67
- SIGA $6.81
- Average True Range (ATR)
- CURI 0.36
- SIGA 0.26
- MACD
- CURI -0.07
- SIGA 0.02
- Stochastic Oscillator
- CURI 21.19
- SIGA 82.50
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.